vspВопросы современной педиатрииCurrent Pediatrics1682-55271682-5535Издательство «ПедиатрЪ»vsp-1373Research ArticleОБЗОРЫ ЛИТЕРАТУРЫLITERATURE REVIEWДИСБИОЗ КИШЕЧНИКА У ДЕТЕЙ С ПИЩЕВОЙ АЛЛЕРГИЕЙ: ПАТОГЕНЕТИЧЕСКИЕ АСПЕКТЫ И СОВРЕМЕННЫЕ МЕТОДЫ КОРРЕКЦИИINTESTINAL DYSBIOSIS IN CHILDREN WITH FOOD ALLERGY: PATHOGENETIC ASPECTS AND MODERN CORRECTION METHODSМакароваС.Г.MakarovaS.G.БоровикТ.Э.BorovikT.E.Научный центр здоровья детей РАМН, МоскваРоссияScientific Center of Children's Health, Russian Academy of Medical Sciences, MoscowRussian Federation20082210201572Вопросы современной педиатрии8292Copyright © Макарова С., Боровик Т., 20082008Макарова С., Боровик Т.Makarova S., Borovik T.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://vsp.spr-journal.ru/jour/article/view/1373ReferencesKalliomaki M., Kirjavainen P., Eerola E. et al. Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. J. Allergy Clinical Immunology. 2001; 107: 129–134.Kalliomaki M., Kirjavainen P., Eerola E. et al. Distinct patterns of neonatal gut microflora in infants developing or not developing atopy. J. Allergy Clinical Immunology. 2001; 107: 129–134.Ouwehand A.C., Isolauri E., He F. et al. Differences in Bifidobacterium flora composition in allergic and healthy infants. Journal of Allergy and Clinical Immunology. 2001; 108: 144–145.Ouwehand A.C., Isolauri E., He F. et al. Differences in Bifidobacterium flora composition in allergic and healthy infants. Journal of Allergy and Clinical Immunology. 2001; 108: 144–145.Ogden N.S., Bielory L. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Current Opinion in Allergy and Clinical Immunology. 2005; 5: 179–184.Ogden N.S., Bielory L. Probiotics: a complementary approach in the treatment and prevention of pediatric atopic disease. Current Opinion in Allergy and Clinical Immunology. 2005; 5: 179–184.Куваева И.Б., Ладодо К.С. Микро–экологические и иммунные нарушения у детей. М.: Медицина. 1991. 432 c.Куваева И.Б., Ладодо К.С. Микро–экологические и иммунные нарушения у детей. М.: Медицина. 1991. 432 c.Балаболкин И.И., Гребенюк В.Н. Атопический дерматит у детей. М.: Медицина. 1999. 240 с.Балаболкин И.И., Гребенюк В.Н. Атопический дерматит у детей. М.: Медицина. 1999. 240 с.Макарова С.Г., Боровик Т.Э., Ладодо К.С. и др. Состояние кишечного микробиоценоза у детей с атопическим дерматитом в зависимости от особенностей клинической картины и формы заболевания. Педиатрия. 1997; 2: 19–24.Макарова С.Г., Боровик Т.Э., Ладодо К.С. и др. Состояние кишечного микробиоценоза у детей с атопическим дерматитом в зависимости от особенностей клинической картины и формы заболевания. Педиатрия. 1997; 2: 19–24.Isolauri E., Gotteland M., Heyman M. et al. Antigen absorption in rabbit bacterial diarrhea. Dig. Dis. Sci. 1990; 35: 350–366.Isolauri E., Gotteland M., Heyman M. et al. Antigen absorption in rabbit bacterial diarrhea. Dig. Dis. Sci. 1990; 35: 350–366.Batt R.M., Hall E.J., McLean L., Simpson K.W. Small intestinal bacterial overgrowth and enhanced intestinal permeability in healthy beagles. Am J. Vet. Res. 1992; 53 (10): 1935–1940.Batt R.M., Hall E.J., McLean L., Simpson K.W. Small intestinal bacterial overgrowth and enhanced intestinal permeability in healthy beagles. Am J. Vet. Res. 1992; 53 (10): 1935–1940.Salzman A.L., Wang H., Wollert P.S. et al. Endotoxin induced ileal mucosal hyperpermeability in pigs: role of tissue acidosis. Am. J. Physiol. 1994; 266 (4): 633–646.Salzman A.L., Wang H., Wollert P.S. et al. Endotoxin induced ileal mucosal hyperpermeability in pigs: role of tissue acidosis. Am. J. Physiol. 1994; 266 (4): 633–646.Беклемишев Е.Д., Суходоева Д.С. Аллергия к микробам в клинике и эксперименте. М.: Медицина. 1979. 315 с.Беклемишев Е.Д., Суходоева Д.С. Аллергия к микробам в клинике и эксперименте. М.: Медицина. 1979. 315 с.Martin R.R., White A. The in vitro release of leukocyte histamine by staphylococcal antigens. J. Immunology. 1969; 102: 437–441.Martin R.R., White A. The in vitro release of leukocyte histamine by staphylococcal antigens. J. Immunology. 1969; 102: 437–441.Espersen F., Jarlov J.О., Jensen C. et al. Staphylococcus aureus peptidoglican induces histamine release from basophil human leukocytes in vitro. Infection and Immunity. 1984; 46: 710–714.Espersen F., Jarlov J.О., Jensen C. et al. Staphylococcus aureus peptidoglican induces histamine release from basophil human leukocytes in vitro. Infection and Immunity. 1984; 46: 710–714.GrossBWeege V., Konig V., Scheffer J., Nimmich W. Induction of histamine release from rat mast cells and human basophilic granulocites by clinical Escherihia coli isolates and relation to hemolysin production and adhesin expression. J. Clinical Microbiology. 1988; 26 (9): 1831–1837.GrossBWeege V., Konig V., Scheffer J., Nimmich W. Induction of histamine release from rat mast cells and human basophilic granulocites by clinical Escherihia coli isolates and relation to hemolysin production and adhesin expression. J. Clinical Microbiology. 1988; 26 (9): 1831–1837.Norn S., Jarlov J.0., Jensen С. et al. Bacteria and their products peptidoglycan and teichoic acid potentiate antigen induced histamine release in allergic patients. Agents and Actions. 1987; 20: 174–179.Norn S., Jarlov J.0., Jensen С. et al. Bacteria and their products peptidoglycan and teichoic acid potentiate antigen induced histamine release in allergic patients. Agents and Actions. 1987; 20: 174–179.Jensen C., Norn S., Stahl Skov P. et al. Bacterial histamine release by immunological and nonBimmunological lectin mediated reactions. Allergy. 1986; 39: 371–377.Jensen C., Norn S., Stahl Skov P. et al. Bacterial histamine release by immunological and nonBimmunological lectin mediated reactions. Allergy. 1986; 39: 371–377.Адо А.Д. Аллергия без иммунологии. Клиническая медицина. 1983; 5: 4–7.Адо А.Д. Аллергия без иммунологии. Клиническая медицина. 1983; 5: 4–7.Smith A.M., Hayden M.A., McCay S.G. et al. Detection and confirmation of histamineBproducing bacteria. Bull. Envirom. Contam. Toxicol. 1982; 29: 618–623.Smith A.M., Hayden M.A., McCay S.G. et al. Detection and confirmation of histamineBproducing bacteria. Bull. Envirom. Contam. Toxicol. 1982; 29: 618–623.NugonBBaudon L., Szylit O., Chaignean M. et al. Production diamines in vitro et in vivo par une souche de lactobacille isolee d'un jabot de cag. Ann. Inst. Pasteur Microbiol. 1985; 136: 63–73.NugonBBaudon L., Szylit O., Chaignean M. et al. Production diamines in vitro et in vivo par une souche de lactobacille isolee d'un jabot de cag. Ann. Inst. Pasteur Microbiol. 1985; 136: 63–73.Шендеров Б.А., Климнюк С.И., Кардашева Е.В. Медицинские аспекты микробной экологии. М. 1994. Ч. 1. Вып. 7–8. С. 71–82.Шендеров Б.А., Климнюк С.И., Кардашева Е.В. Медицинские аспекты микробной экологии. М. 1994. Ч. 1. Вып. 7–8. С. 71–82.Мазитова О.И., Фиш Н.Г., Кулинич Л.И. и др. Оценка сенсибилизации к кишечной микрофлоре при аллергических заболеваниях. Советская медицина. 1987; 5: 31–33.Мазитова О.И., Фиш Н.Г., Кулинич Л.И. и др. Оценка сенсибилизации к кишечной микрофлоре при аллергических заболеваниях. Советская медицина. 1987; 5: 31–33.Dhar S., Kanwar A.J., Kaur S. et al. Role of bacterial flora in the pathogenesis and management of atopic dermatitis. Indian. J. Med. Res. 1992; 95: 234–238.Dhar S., Kanwar A.J., Kaur S. et al. Role of bacterial flora in the pathogenesis and management of atopic dermatitis. Indian. J. Med. Res. 1992; 95: 234–238.Leung D.Y., Harbeck R., Bina P. et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J. Clin. Invest. 1993; 92 (3): 1374–1380.Leung D.Y., Harbeck R., Bina P. et al. Presence of IgE antibodies to staphylococcal exotoxins on the skin of patients with atopic dermatitis. Evidence for a new group of allergens. J. Clin. Invest. 1993; 92 (3): 1374–1380.Макарова С.Г., Боровик Т.Э., Балаболкин И.И. Роль диетотерапии в коррекции дисбиотических нарушений у детей раннего возраста с атопическим дерматитом, обусловленным пищевой сенсибилизацией. Вопросы детской диетологии. 2003; 1: 34–38.Макарова С.Г., Боровик Т.Э., Балаболкин И.И. Роль диетотерапии в коррекции дисбиотических нарушений у детей раннего возраста с атопическим дерматитом, обусловленным пищевой сенсибилизацией. Вопросы детской диетологии. 2003; 1: 34–38.Макарова С.Г., Балаболкин И.И., Боровик Т.Э. Пищевая аллергия и дисбактериоз кишечника. Диетологические подходы. Вопросы детской диетологии. 2004; 2 (1): 56.Макарова С.Г., Балаболкин И.И., Боровик Т.Э. Пищевая аллергия и дисбактериоз кишечника. Диетологические подходы. Вопросы детской диетологии. 2004; 2 (1): 56.He F., Ouwehand A.C., Isolauri E. et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunology and Medical Microbiology. 2001; 30: 43–47.He F., Ouwehand A.C., Isolauri E. et al. Comparison of mucosal adhesion and species identification of bifidobacteria isolated from healthy and allergic infants. FEMS Immunology and Medical Microbiology. 2001; 30: 43–47.Laiho K., Hoppu U., Ouwehand A.C. et al. Probiotics: on going research on atopic individuals. British J. Nutrition. 2002; 88 (1): 19–27.Laiho K., Hoppu U., Ouwehand A.C. et al. Probiotics: on going research on atopic individuals. British J. Nutrition. 2002; 88 (1): 19–27.Morelli L. Probiotics: clinics and/or nutrition. Digest Liver Dis. 2002; 34 (2): 8–11.Morelli L. Probiotics: clinics and/or nutrition. Digest Liver Dis. 2002; 34 (2): 8–11.Sutas Y., Hurme M. & Isolauri E. DownBregulation of antiBCD3 antibody induced IL 4 production by bovine caseins hydrolysed with Lactobacillus GGBderived enzymes. Scandinavian J. Immunology. 1996; 43: 687–689.Sutas Y., Hurme M. & Isolauri E. DownBregulation of antiBCD3 antibody induced IL 4 production by bovine caseins hydrolysed with Lactobacillus GGBderived enzymes. Scandinavian J. Immunology. 1996; 43: 687–689.Wollowski I., Rechkemmer G., PoolBZobel B.L. Protective role of probiotics and prebiotics in colon cancer. American Journal of Clinical Nutrition. 2001; 73: 451–455.Wollowski I., Rechkemmer G., PoolBZobel B.L. Protective role of probiotics and prebiotics in colon cancer. American Journal of Clinical Nutrition. 2001; 73: 451–455.Pessi T., Sutas Y., Marttinen A. & Isolauri E. Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics. J. Nutrition. 1998; 128: 1312–1318.Pessi T., Sutas Y., Marttinen A. & Isolauri E. Probiotics reinforce mucosal degradation of antigens in rats: implications for therapeutic use of probiotics. J. Nutrition. 1998; 128: 1312–1318.Majamaa H., Isolauri E., Saxelin M & Veskari T () Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatric Gastroenterology Nutrition. 1995; 20: 333–338.Majamaa H., Isolauri E., Saxelin M & Veskari T () Lactic acid bacteria in the treatment of acute rotavirus gastroenteritis. J. Pediatric Gastroenterology Nutrition. 1995; 20: 333–338.Yasui H., Nagaoka N., Mike A. et al. Detection of Bifidobacterium strains that induce large quantities of IgA. Microbiol. Ecology Health Disease. 1992; 5: 155–162.Yasui H., Nagaoka N., Mike A. et al. Detection of Bifidobacterium strains that induce large quantities of IgA. Microbiol. Ecology Health Disease. 1992; 5: 155–162.Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J. Dairy Science. 1998; 81: 48–53.Matsuzaki T., Yamazaki R., Hashimoto S., Yokokura T. The effect of oral feeding of Lactobacillus casei strain Shirota on immunoglobulin E production in mice. J. Dairy Science. 1998; 81: 48–53.Kirjavainen P.V., Apostolou E., Salminen S.J., Isolauri E. New aspects of probiotics — a novel approach in the management of food allergy. Allergy. 1999; 54: 909–915.Kirjavainen P.V., Apostolou E., Salminen S.J., Isolauri E. New aspects of probiotics — a novel approach in the management of food allergy. Allergy. 1999; 54: 909–915.Sanfilippo L., Li C.K., Seth R. et al. Bacteroides fragilis enterotoxin induces the expression of IL 8 and transforming growth factor beta (TGFBbeta) by human colonic epithelial cells. Clinical Exp. Immunol. 2000; 119: 456–463.Sanfilippo L., Li C.K., Seth R. et al. Bacteroides fragilis enterotoxin induces the expression of IL 8 and transforming growth factor beta (TGFBbeta) by human colonic epithelial cells. Clinical Exp. Immunol. 2000; 119: 456–463.Benno Y., He F., Hosoda M. et al. Effect of Lactobacillus GG yogurt on human intestinal microecology in Japanese subjects. Nutrition Today. 1996; 31 (Suppl. 6): 9–11.Benno Y., He F., Hosoda M. et al. Effect of Lactobacillus GG yogurt on human intestinal microecology in Japanese subjects. Nutrition Today. 1996; 31 (Suppl. 6): 9–11.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357: 1076–1079.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357: 1076–1079.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlle trial. Lancet. 2001; 357: 1076–1079.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlle trial. Lancet. 2001; 357: 1076–1079.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357: 1076–1079.Kalliomaki M., Salminen S., Arvilommi H. et al. Probiotics in primary prevention of atopic disease: a randomised placebo-controlled trial. Lancet. 2001; 357: 1076–1079.Pessi T., Sutas Y., Hurme M. et al. Interleukin 10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy. 2000; 30: 1804–1808.Pessi T., Sutas Y., Hurme M. et al. Interleukin 10 generation in atopic children following oral Lactobacillus rhamnosus GG. Clin. Exp. Allergy. 2000; 30: 1804–1808.Kalliomaki M., Isolauri E. Pandemic of atopic diseases — a lack of microbial exposure in early infancy? Curr. Drug Targets Infect. Disord. 2002; 2: 193–199.Kalliomaki M., Isolauri E. Pandemic of atopic diseases — a lack of microbial exposure in early infancy? Curr. Drug Targets Infect. Disord. 2002; 2: 193–199.Kalliomaki M., Salminen S., Poussa T. et al. Probiotics and prevention of atopic disease: 4Byear followBup of a randomised placebo-controlled trial. Lancet. 2003; 361: 1869–1871.Kalliomaki M., Salminen S., Poussa T. et al. Probiotics and prevention of atopic disease: 4Byear followBup of a randomised placebo-controlled trial. Lancet. 2003; 361: 1869–1871.Isolauri E., Arvola T., Sutas Y. et al. Probiotics in the management of atopic eczema. Clin. Exp. Allergy. 2000; 30: 1604–1610.Isolauri E., Arvola T., Sutas Y. et al. Probiotics in the management of atopic eczema. Clin. Exp. Allergy. 2000; 30: 1604–1610.Penttila I. Effects of transforming growth factor beta and formula feeding on systemic immune responses to dietary beta lacto globulin in allergy prone rats. Pediatr. Res. 2006; 59 (5): 650–655.Penttila I. Effects of transforming growth factor beta and formula feeding on systemic immune responses to dietary beta lacto globulin in allergy prone rats. Pediatr. Res. 2006; 59 (5): 650–655.Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against disease in the infant. J. Allergy Clin. Immunol. 2002; 109 (1): 119–121.Rautava S., Kalliomaki M., Isolauri E. Probiotics during pregnancy and breastfeeding might confer immunomodulatory protection against disease in the infant. J. Allergy Clin. Immunol. 2002; 109 (1): 119–121.Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997; 99: 179–185.Majamaa H., Isolauri E. Probiotics: a novel approach in the management of food allergy. J. Allergy Clin. Immunol. 1997; 99: 179–185.Bai А.Р., Ouyang Q., Zhang W. et al. Probiotics inhibit TNFA induced interleukin 8 secretion of HT29 cells. J. Gastroenterology. 2004; 10 (3): 455–457.Bai А.Р., Ouyang Q., Zhang W. et al. Probiotics inhibit TNFA induced interleukin 8 secretion of HT29 cells. J. Gastroenterology. 2004; 10 (3): 455–457.Rosenfeldt V., Benfeldt E., Nielsen S.D. et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 2003; 112: 223–227.Rosenfeldt V., Benfeldt E., Nielsen S.D. et al. Effect of probiotic Lactobacillus strains in children with atopic dermatitis. J. Allergy Clin. Immunol. 2003; 112: 223–227.Mastrandrea F., Coradduzza G., Serio G. et al. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Allerg. Immunol. 2004; 36: 118–122.Mastrandrea F., Coradduzza G., Serio G. et al. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Allerg. Immunol. 2004; 36: 118–122.Hattori K., Yamamoto A., Sasai M. et al. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi. 2003; 52: 20–30.Hattori K., Yamamoto A., Sasai M. et al. Effects of administration of bifidobacteria on fecal microflora and clinical symptoms in infants with atopic dermatitis. Arerugi. 2003; 52: 20–30.Laiho K., Hoppu U., Ouwehand A.C. et al. Probiotics: on going research on atopic individuals. British J. Nutrition. 2002; 1 (88): 19–27.Laiho K., Hoppu U., Ouwehand A.C. et al. Probiotics: on going research on atopic individuals. British J. Nutrition. 2002; 1 (88): 19–27.Gibson G.R., Roberfroid М. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995; 1256: 1401–1412.Gibson G.R., Roberfroid М. Dietary modulation of the human colonic microbiota: Introducing the concept of prebiotics. J. Nutr. 1995; 1256: 1401–1412.Roberfroid M.B. InulinBtype fructans: functional food ingredients. J. Nutr. 2007; 137: 830–837.Roberfroid M.B. InulinBtype fructans: functional food ingredients. J. Nutr. 2007; 137: 830–837.European Society of Pediatric Allergy and Clinical Immunology. Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position. Pediatr. Allergy Immunol. 1995; 6: 56.European Society of Pediatric Allergy and Clinical Immunology. Hydrolysed cow's milk formulae. Allergenicity and use in treatment and prevention. An ESPACI position. Pediatr. Allergy Immunol. 1995; 6: 56.ESPGAN Committee on Nutrition. Comment on antigen reduced infant formulae. Acta Paediatr. 1993; 82: 314–319.ESPGAN Committee on Nutrition. Comment on antigen reduced infant formulae. Acta Paediatr. 1993; 82: 314–319.Макарова С.Г., Боровик Т.Э., Балаболкин И.И., Ревякина В.А. Использование продуктов, способствующих нормализации кишечного биоценоза, при пищевой аллергии у детей раннего возраста. Аллергология. 2001; 1: 29–33.Макарова С.Г., Боровик Т.Э., Балаболкин И.И., Ревякина В.А. Использование продуктов, способствующих нормализации кишечного биоценоза, при пищевой аллергии у детей раннего возраста. Аллергология. 2001; 1: 29–33.Мазанкова Л.Н., Лыкова Е.А., Шевелева С.А. Пробиотики: систематизация препаратов и тактика их применения у детей. Вестник педиатрической фармакологии нутрициологии. 2005; 2 (3): 4–10.Мазанкова Л.Н., Лыкова Е.А., Шевелева С.А. Пробиотики: систематизация препаратов и тактика их применения у детей. Вестник педиатрической фармакологии нутрициологии. 2005; 2 (3): 4–10.Урсова Н.И. Дисбактериозы кишечника у детей. Руководство для врачей. М. 2006. 240. сУрсова Н.И. Дисбактериозы кишечника у детей. Руководство для врачей. М. 2006. 240. сОсипова И.Г. Экспериментально–клиническое изучение споровых пробиотиков. Автореф. дис. … докт. мед. наук. М. 2006. 48 c.Осипова И.Г. Экспериментально–клиническое изучение споровых пробиотиков. Автореф. дис. … докт. мед. наук. М. 2006. 48 c.Щербаков П.Л., Петухов В.А. Сравнительная эффективность энтеросорбентов при диарее у детей. Вопросы современной педиатрии. 2005; 4 (4): 86–90.Щербаков П.Л., Петухов В.А. Сравнительная эффективность энтеросорбентов при диарее у детей. Вопросы современной педиатрии. 2005; 4 (4): 86–90.
The authors declare that there are no conflicts of interest present.